Cover Image

Guidance for industry : S8 immunotoxicity studies for human pharmaceuticals.

Bibliographic Details
Corporate Authors:	Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.), International Conference on Harmonisation
Format:	Government Document Conference Proceeding eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2006]
Subjects:	Immunotoxicology. Drugs > Testing.
Online Access:	https://purl.fdlp.gov/GPO/LPS113859

Similar Items

Identifying and controlling immunotoxic substances.
Published: (1991)

Identifying and controlling immunotoxic substances.
Published: (1991)

Guidance for industry : immunotoxicology evaluation of investigational new drugs.
Published: (2002)

Immunotoxicity of the halogenated aromatic hydrocarbons- QSARs and interactive effects /
by: Davis, De Ann Marie Pospisil, 1962-
Published: (1989)

Assessing immunotoxicity risks from exposure to complex mixtures of environmental contaminants /
by: Lochmiller, R. L. (Robert Lee), 1954-
Published: (1994)

Antiestrogenic and immunotoxic effects of polychlorinated dibenzo-p-dioxins and dibenzofurans : mechanistic studies /
by: Dickerson, Richard Lee, 1952-
Published: (1992)

IMMUNOTOXICOGENOMICS a multidisciplinary approach in systems toxicology.
Published: (2023)

Immunotoxicology and immunopharmacology /
Published: (2007)

Immunotoxicology strategies for pharmaceutical safety assessment /
Published: (2008)

Immunotoxicology of drugs and chemicals. an experimental and clinical approach /
by: Descotes, Jacques, 1925-
Published: (2004)

Guidance for industry : S7A safety pharmacology studies for human pharmaceuticals.
Published: (2001)

Immunotoxicology : proceedings of the First International Symposium on Immunotoxicology, held at the University of Surrey, 13-17 September 1982 /
Published: (1983)

Guidance for industry : S1B testing for carcinogenicity of pharmaceuticals.
Published: (1997)

Immunotoxicology of drugs and chemicals : an experimental and clinical approach /
by: Descotes, Jacques, 1925-
Published: (2004)

Isolation of a toxic metabolite from a thermotolerant strain of Penicillium citrinum : immunological and developmental studies /
by: Yang, Yung Gung
Published: (1991)

In vitro effects of mineral dusts : third international workshop /
Published: (1985)

Molecular immunotoxicology /
Published: (2014)

Guidance for industry : S6 preclinical safety evaluation of biotechnology-derived pharmaceuticals.
Published: (1997)

Guidance for industry : M3 nonclinical safety studies for the conduct of human clinical trials for pharmaceuticals.
Published: (1997)

Guidance for industry : statistical aspects of the design, analysis, and interpretation of chronic rodent carcinogenicity studies of pharmaceuticals.
Published: (2001)

Guidance for industry : investigating out-of-specification test results (OOS) for pharmaceutical production.
Published: (2006)

Guidance for industry : S2B genotoxicity, a standard battery for genotoxicity testing of pharmaceuticals.
Published: (1997)

Guidance for industry : S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT Interval Prolongation) by human pharmaceuticals.
Published: (2005)

Guidance for industry : stability testing, photostability testing of new veterinary drug substances and medicinal products.
Published: (1999)

Guidance for industry : CGMP for phase 1 investigational drugs.
Published: (2008)

Guidance for industry : Q1A(R2) stability testing of new drug substances and products.
Published: (2003)

Guidance for industry : single dose acute toxicity testing for pharmaceuticals.
Published: (1996)

Guidance for industry : Q1D bracketing and matrixing designs for stability testing of new drug substances and products.
Published: (2003)

Guidance for industry : estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers.
Published: (2005)

Guidance for industry : Q1E evaluation of stability data.
Published: (2004)

Guidance for industry : S1C(R2) dose selection for carcinogenicity studies.
Published: (2008)

Guidance for industry : photosafety testing.
Published: (2003)

Guidance for industry : stability testing of new veterinary dosage forms.
Published: (1999)

Guidance for industry : tropical disease priority review vouchers.
Published: (2008)

Guidance for industry : drug-induced liver injury, premarketing clinical evaluation.
Published: (2007)

Immunotoxic effects of polychlorinated diphenyl ethers, biphenyls and dibenzofurans : quantitative structure-activity relationships and role of the Ah receptor /.
by: Howie, Laura Elizabeth, 1965-
Published: (1992)

Guidance for industry : nonclinical safety evaluation of drug or biologic combinations.
Published: (2006)

In vitro effects of mineral dusts : third international workshop /
Published: (1985)

Guidance for industry : E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs.
Published: (2005)

Guidance for industry : Q3C impurities, residual solvents.
Published: (1997)